Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments.

cell division cell migration colorectal cancer cytospin-A

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Apr 2022
Historique:
received: 04 03 2022
revised: 06 04 2022
accepted: 08 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Proteins that interact with cytoskeletal elements play important roles in cell division and are potentially important targets for therapy in cancer. Cytospin-A (CYTSA), a protein known to interact with actin and microtubules, has been previously described to be important in various developmental disorders, including oblique facial clefting. We hypothesized that CYTSA plays an important role in colorectal cancer (CRC) cell division. The effects of CYTSA depletion on CRC cell proliferation were analyzed using cell growth assays, microscopic analyses of live and fixed cells, and time-lapse imaging. CYTSA depletion led to inhibition of cell proliferation, significant increases in CRC cell death, and accumulation of doublet cells during and following cell division. Depletion of CYTSA also resulted in strong inhibition of CRC cell migration and invasion. Mechanistically, CYTSA depletion resulted in significant decreases in the stability of microtubules and altered polymerization of actin filaments in CRC cells. Finally, bioinformatic analyses were performed to determine the correlation between CYTSA expression and survival of patients with CRC. Interestingly, a strong correlation between high CYTSA expression and poor survival was observed in the TCGA adenocarcinoma data set but not in an independent data set. Since inhibiting CYTSA significantly reduces CRC cell proliferation, migration, and invasion, targeting CYTSA may be a potential novel therapeutic option for patients with metastatic CRC.

Identifiants

pubmed: 35454887
pii: cancers14081977
doi: 10.3390/cancers14081977
pmc: PMC9026928
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : United States Department of Defense
ID : CA181043
Organisme : Gillson-Longenbaugh Foundation
ID : Foundation grant
Organisme : University of Texas MD Anderson Cancer Center
ID : Internal Research Grant
Organisme : NIH HHS
ID : CA157880
Pays : United States
Organisme : NIH HHS
ID : P30CA016672
Pays : United States

Références

PLoS One. 2018 Jan 2;13(1):e0190070
pubmed: 29293549
Curr Opin Cell Biol. 1998 Feb;10(1):123-30
pubmed: 9484604
J Cell Biol. 2000 Aug 7;150(3):539-52
pubmed: 10931866
Annu Rev Cell Dev Biol. 2013;29:417-41
pubmed: 23875646
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20449-54
pubmed: 24284166
Sci Rep. 2016 Jan 20;6:17735
pubmed: 26787558
Cell. 1980 May;20(1):29-36
pubmed: 7388944
Cold Spring Harb Perspect Biol. 2018 May 1;10(5):
pubmed: 29716949
Physiol Rev. 2003 Apr;83(2):433-73
pubmed: 12663865
Cell Mol Life Sci. 2006 Sep;63(18):2119-34
pubmed: 16909206
Eur J Med Genet. 2019 Dec;62(12):103588
pubmed: 30472488
Hum Mol Genet. 2021 Dec 17;31(1):18-31
pubmed: 34302166
Br J Cancer. 2017 Sep 5;117(6):848-855
pubmed: 28742793
Cell. 1976 Jan;7(1):1-11
pubmed: 779953
Genome Biol. 2005;6(1):204
pubmed: 15642108
J Med Genet. 2015 Feb;52(2):104-10
pubmed: 25412741
Hum Mol Genet. 2020 Mar 27;29(5):845-858
pubmed: 31943082
Mod Pathol. 2021 Jan;34(1):95-103
pubmed: 32669612
J Thorac Oncol. 2019 Feb;14(2):e27-e29
pubmed: 30683294
Curr Biol. 2008 Jan 8;18(1):30-6
pubmed: 18158243
Am J Surg Pathol. 2019 Oct;43(10):1384-1391
pubmed: 31219820
Am J Surg Pathol. 2020 Apr;44(4):567-570
pubmed: 31917708
Annu Rev Biophys. 2011;40:169-86
pubmed: 21314430
Lung Cancer. 2020 May;143:97-100
pubmed: 32216970
Am J Hum Genet. 2011 Jul 15;89(1):44-55
pubmed: 21703590
Mol Biol Cell. 2011 Apr;22(7):1025-34
pubmed: 21289088
Cold Spring Harb Perspect Biol. 2016 Aug 01;8(8):
pubmed: 26988969
Clin Colorectal Cancer. 2021 Jun;20(2):137-147.e1
pubmed: 33229221
Clin Cancer Res. 2007 May 15;13(10):2849-54
pubmed: 17504982
Nat Rev Mol Cell Biol. 2010 Apr;11(4):276-87
pubmed: 20308985
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Cold Spring Harb Mol Case Stud. 2020 Dec 17;6(6):
pubmed: 33144287
Plast Reconstr Surg. 2014 Oct;134(4):748-759
pubmed: 25357034
Annu Rev Biochem. 2000;69:277-302
pubmed: 10966460
Nat Rev Cancer. 2004 Apr;4(4):253-65
pubmed: 15057285
Cell Cycle. 2011 Mar 1;10(5):783-93
pubmed: 21325884

Auteurs

Fan Fan (F)

Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Jason Roszik (J)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Ling Xia (L)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Susmita Ghosh (S)

Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Rui Wang (R)

Department of Surgery, Case Western Reserve University, Cleveland, OH 44106, USA.

Xiangcang Ye (X)

Department of Nutrition, Texas A&M University, College Station, TX 77843, USA.

David Hawke (D)

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Lee M Ellis (LM)

Departments of Colon and Rectal Surgery and Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Rajat Bhattacharya (R)

Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH